Resisting degradation by human elastase: Commonality of design features shared by ‘canonical’ plant and bacterial macrocyclic protease inhibitor scaffolds-Reference-Cited by-同舟云学术

Resisting degradation by human elastase: Commonality of design features shared by ‘canonical’ plant and bacterial macrocyclic protease inhibitor scaffolds

Published:2007-07 Issue:13 Volume:15 Page:4618-4628
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Brauer Arnd B.E.,McBride Jeffrey D.,Kelly Geoff,Matthews Stephen J.,Leatherbarrow Robin J.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference95 articles.

1. Structure of porcine pancreatic elastase complexed with FR901277, a novel macrocyclic inhibitor of elastases, at 1.6 Å resolution

2. Natural protein proteinase inhibitors and their interaction with proteinases

3. Structural basis of the endoproteinase–protein inhibitor interaction

4. What can the structures of enzyme-inhibitor complexes tell us about the structures of enzyme substrate complexes?

5. Evolutionary families of peptidase inhibitors

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ahp Cyclodepsipeptides: The Impact of the Ahp Residue on the “Canonical Inhibition” of S1 Serine Proteases;ChemBioChem;2013-06-21

2. Braces for the Peptide Backbone: Insights into Structure-Activity Relationships of Protease Inhibitor Mimics with Locked Amide Conformations;Angewandte Chemie International Edition;2012-02-28

3. Peptid in Ketten: Einblicke in die Struktur-Aktivitäts-Beziehungen von Proteaseinhibitormimetika mit fixierten Amidkonformationen;Angewandte Chemie;2012-02-28

4. Development of a Solid-Phase Approach to the Natural Product Class of Ahp-Containing Cyclodepsipeptides;European Journal of Organic Chemistry;2012-01-23

5. The exploration of macrocycles for drug discovery — an underexploited structural class;Nature Reviews Drug Discovery;2008-07